Mosaic Biosciences, Inc.
Antibody discovery and protein engineering platform with function-first screening and developability assessment services
- Sector
- Biotech
- Headquarters
- BOULDER, CO
- Founded
- 2009
- Latest Form D
- $11.4M, Jan 2023
- Total capital
- $14.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $14.7M
- 3 Form D · last Jan 2023
- 46 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 8
- 9 pending · first 2018
- Rank in peer group#28 of 342
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$11.4M
- Private capital raisedForm D · SEC · 2nd filing$2.3M
- Private capital raisedForm D · SEC · 1st filing$1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#28 · top 8%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Augustine LawlorDirectorNamed in SEC Form D filings
- Dan MitchellDirectorNamed in SEC Form D filings
- Eric FurfineDirectorNamed in SEC Form D filings
- Guy KatsavDirectorNamed in SEC Form D filings
- Jeanette WelshDirectorNamed in SEC Form D filings
- Mark LupaDirectorNamed in SEC Form D filings
Show all 9 people
- Martin StantonExecutive Officer, DirectorNamed in SEC Form D filings
- Nassim UsmanDirectorNamed in SEC Form D filings
- Rob CaponeDirectorNamed in SEC Form D filings
What it has protected
USPTO · 8 granted of 17- GrantedMethod For Producing Nucleic Acid Molecule, Biomaterial, And Method For Producing BiomaterialUSPTOUS 12,595,480
- GrantedMethod For Producing Nucleic Acid Molecule, Biomaterial, And Method For Producing BiomaterialUSPTOUS 11,613,748
- GrantedDegradable Thiol-ene Polymers And Methods Of Making ThereofUSPTOUS 11,439,711
Show all 17 patent records
- Method For Producing Nucleic Acid Molecule, Biomaterial, And Method For Producing BiomaterialApr 7, 2026 · US 12,595,480Granted
- Method For Producing Nucleic Acid Molecule, Biomaterial, And Method For Producing BiomaterialMar 28, 2023 · US 11,613,748Granted
- Degradable Thiol-ene Polymers And Methods Of Making ThereofSep 13, 2022 · US 11,439,711Granted
- Degradable Polymeric Tissue ScaffoldAug 4, 2022 · Application 17611111Pending
- Covalent Modification Of Biological MacromoleculesJul 21, 2022 · Application 17458075Pending
- Biomaterials For Delivery Of Blood Extracts And Methods Of Using SameNov 2, 2021 · US 11,160,866Granted
- Covalent Modification Of Biological MacromoleculesSep 28, 2021 · US 11,130,797Granted
- Degradable Thiol-ene Polymers And Methods Of Making ThereofFeb 9, 2021 · US 10,912,837Granted
- Biomaterials For Delivery Of Blood Extracts And Methods Of Using SameJul 10, 2018 · US 10,016,505Granted
- Covalent Modification Of Biological MacromoleculesJun 5, 2018 · US 9,988,433Granted
- Degradable Thiol-ene Polymers And Methods Of Making ThereofApplication 62114034Pending
- Covalent Modification Of Biological MacromoleculesApplication 61782107Pending
- Degradable Polymeric Tissue ScaffoldApplication 62847864Pending
- Biomaterials For Delivery Of Blood Extracts And Methods Of Using SameApplication PCTUS2013024520Pending
- Degradable Polymeric Tissue ScaffoldApplication 62847866Pending
- Degradable Polymeric Tissue ScaffoldApplication PCTUS2020032932Pending
- Degradable Thiol-ene Polymers And Methods Of Making ThereofApplication PCTUS2016017189Pending
Related companies, and why
- Outpace BioSimilar federal contract value in Biotech · null in contracts
- Chemomab Therapeutics Ltd.Similar federal contract value in Biotech · null in contracts
- Lumena Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- Resolve Therapeutics LLCSimilar federal contract value in Biotech · null in contracts
- Strategic Science & Technologies LLCSimilar federal contract value in Biotech · null in contracts
- Stem Cell Reserve, LPSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .